These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38222070)

  • 1. miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis.
    Khedr AM; Shaker OG; El-Komy MH; Badr AM; Erfan R
    Noncoding RNA Res; 2024 Mar; 9(1):253-261. PubMed ID: 38222070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Long Noncoding RNA, HOTAIR, and MicroRNA-205 and Their Relation to Transforming Growth Factor β
    Mohamad N; Khedr AMB; Shaker OG; Hassan M
    Skin Appendage Disord; 2023 Mar; 9(2):111-120. PubMed ID: 36937162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Cell-Free Long Non-Coding RNA-H19 and miRNA-29a, miRNA-29b Expression and Severity of Diabetes.
    Alfaifi M; Verma AK; Alshahrani MY; Joshi PC; Alkhathami AG; Ahmad I; Hakami AR; Beg MMA
    Diabetes Metab Syndr Obes; 2020; 13():3727-3737. PubMed ID: 33116722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
    Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a Suggested Model of Fibrosis in Human Dermal Fibroblasts by Serum from Systemic Sclerosis Patients with Transforming Growth Factor β Induced in vitro Model.
    Dadashzadeh E; Saghaeian Jazi M; Abdolahi N; Mohammadi S; Saeidi M
    Int J Mol Cell Med; 2022; 11(1):31-40. PubMed ID: 36397805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.
    Steen SO; Iversen LV; Carlsen AL; Burton M; Nielsen CT; Jacobsen S; Heegaard NH
    J Rheumatol; 2015 Feb; 42(2):214-21. PubMed ID: 25399392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessing the Role of the Active TGF-
    Dantas AT; Gonçalves SM; de Almeida AR; Gonçalves RS; Sampaio MC; Vilar KM; Pereira MC; Rêgo MJ; Pitta ID; Marques CD; Duarte AL; Pitta MG
    Dis Markers; 2016; 2016():6064830. PubMed ID: 27965520
    [No Abstract]   [Full Text] [Related]  

  • 9. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease.
    Xiong G; Jiang X; Song T
    Rev Assoc Med Bras (1992); 2019 Feb; 65(2):110-117. PubMed ID: 30892430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement.
    Wajda A; Walczyk M; Dudek E; Stypińska B; Lewandowska A; Romanowska-Próchnicka K; Chojnowski M; Olesińska M; Paradowska-Gorycka A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142646
    [No Abstract]   [Full Text] [Related]  

  • 11. Transforming growth factor beta isoforms and TGF-βR1 and TGF-βR2 expression in systemic sclerosis patients.
    Lomelí-Nieto JA; Muñoz-Valle JF; Baños-Hernández CJ; Navarro-Zarza JE; Godínez-Rubí JM; García-Arellano S; Ramírez-Dueñas MG; Parra-Rojas I; Villanueva-Pérez A; Hernández-Bello J
    Clin Exp Med; 2023 Jun; 23(2):471-481. PubMed ID: 35643962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer.
    Schaalan M; Mohamed W; Fathy S
    Microb Pathog; 2020 Dec; 149():104442. PubMed ID: 32795593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist.
    Cipriani P; Di Benedetto P; Ruscitti P; Capece D; Zazzeroni F; Liakouli V; Pantano I; Berardicurti O; Carubbi F; Pecetti G; Turricchia S; Alesse E; Iglarz M; Giacomelli R
    J Rheumatol; 2015 Oct; 42(10):1808-16. PubMed ID: 26276964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.
    Tomcik M; Zerr P; Palumbo-Zerr K; Storkanova H; Hulejova H; Spiritovic M; Kodet O; Stork J; Becvar R; Vencovsky J; Pavelka K; Filkova M; Distler JH; Senolt L
    Rheumatology (Oxford); 2015 Dec; 54(12):2273-82. PubMed ID: 26231346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
    Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
    Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.
    Tanaka S; Suto A; Ikeda K; Sanayama Y; Nakagomi D; Iwamoto T; Suzuki K; Kambe N; Matsue H; Matsumura R; Kashiwakuma D; Iwamoto I; Nakajima H
    Rheumatology (Oxford); 2013 Nov; 52(11):1963-72. PubMed ID: 23893664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
    Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients.
    Esawy MM; Saleh Al-Sowayan N; Mobasher MA; Abd-Elhameed A; Abd Elbaser ES; Baioumy SA; Shabana MA
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
    Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
    Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.